Xtx Topco LTD Roivant Sciences Ltd. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Xtx Topco LTD holds 55,500 shares of ROIV stock, worth $621,600. This represents 0.05% of its overall portfolio holdings.
Number of Shares
55,500
Previous 25,658
116.31%
Holding current value
$621,600
Previous $271,000
136.16%
% of portfolio
0.05%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$738 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$737 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$606 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$467 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$396 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.89B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...